Epidemiological features of pediatric nonalcoholic fatty liver disease in China

dc.contributor.authorPan, Xiongfeng
dc.contributor.authorMcDonald, Judy
dc.contributor.authorTan, Xinrui
dc.contributor.authorKaminga, Atipatsa C.
dc.contributor.authorLiu, Aizhong
dc.contributor.authorZhao, Kunyan
dc.contributor.authorPeng, Yunlong
dc.contributor.authorLi, Hong-Bao
dc.contributor.authorPeng, Songxu
dc.contributor.authorQiu, Jun
dc.date.accessioned2026-07-07T03:51:40Z
dc.date.issued2026-05-12
dc.date.updated2026-07-07T03:51:40Z
dc.description.abstractAbstract Objective Non-alcoholic fatty-liver disease (NAFLD) among children and adolescents in China has emerged as a significant public-health concern, that requires greater attention. This study aims to estimate the prevalence of pediatric NAFLD and its epidemiological characteristics. Methods Four English-language and two Chinese-language databases were systematically searched for relevant articles published before January 1st, 2025. Rigorous inclusion and exclusion criteria were applied to screen articles and extract NAFLD prevalence data. The pooled overall prevalence of NAFLD with 95% confidence intervals (CIs) was calculated using the Freeman-Tukey Double Arcsine Transformation Method. Moreover, subgroup analysis was conducted to compare NAFLD prevalence across different categories, including region, income, age, and gender. Results The study encompassed 126,682 participants from 219 studies. The nationwide prevalence of pediatric NAFLD in China was 22.82%. Higher prevalence rates were observed among boy, older age groups, individuals in southern and northeastern regions, and those classified as obese or overweight. Furthermore, epidemiological pattern analysis of children with NAFLD identified metabolic, endocrine, and lifestyle factors as crucial determinants in pediatric NAFLD progression. Conclusions Considering the substantial burden of pediatric NAFLD in China, researchers must conduct effective intervention studies to address its epidemiological status. Additionally, governmental action is required to enhance public awareness and establish health policies aimed at controlling the NAFLD epidemic among Chinese children. Trial registration The registration number was CRD42020206731.
dc.identifier.citationDiabetology & Metabolic Syndrome. 2026 May 12;18(1):145
dc.identifier.urihttps://doi.org/10.1186/s13098-025-01973-5
dc.identifier.urihttp://hdl.handle.net/10393/51811
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleEpidemiological features of pediatric nonalcoholic fatty liver disease in China
dc.typeJournal Article

Fichiers

Trousse originale

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
13098_2025_Article_1973.pdf
Taille:
8.08 MB
Format:
Adobe Portable Document Format

Trousse de licence

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
license.txt
Taille:
2.51 KB
Format:
Item-specific license agreed upon to submission
Description: